Pivotal <i>Shigella</i> Vaccine Efficacy Trials—Study Design Considerations from a <i>Shigella</i> Vaccine Trial Design Working Group

Pivotal <i>Shigella</i> Vaccine Efficacy Trials—Study Design Considerations from a <i>Shigella</i> Vaccine Trial Design Working Group

Vaccine candidates for <i>Shigella</i> are approaching phase 3 clinical trials in the target population of young children living in low- and middle-income countries. Key study design decisions will need to be made to maximize the success of such trials and minimize the time to licensure...

Full description

Bibliographic Details
Main Authors: Patricia B. Pavlinac, Elizabeth T. Rogawski McQuade, James A. Platts-Mills, Karen L. Kotloff, Carolyn Deal, Birgitte K. Giersing, Richard A. Isbrucker, Gagandeep Kang, Lyou-Fu Ma, Calman A. MacLennan, Peter Patriarca, Duncan Steele, Kirsten S. Vannice
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Vaccines
Subjects:
vaccine trial design
pediatrics
low and middle-income countries
<i>Shigella</i>
Online Access:https://www.mdpi.com/2076-393X/10/4/489

Internet

https://www.mdpi.com/2076-393X/10/4/489

Similar Items